COV vs EBR

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

COV

CLEO DIAGN FPO [COV]

47LOW

EBR

EBR SYSTEM CDI FORUS [EBR]

47LOW

Score Breakdown

COV EBR
Technical
67
57
Catalyst
55
50
Sentiment
50
50
Fundamental
65
66
Momentum
76
33
Risk Gate
46
46

Key Metrics

COV Metric EBR
$65.0MMarket Cap$322.1M
193KAvg Volume (20d)465K
N/AShort Interest+0.0%
$0.90052-Week High$2.080
$0.31052-Week Low$0.640
+19.4%Daily Change+0.0%
$0.555Entry Price$0.685
-49.6%ROE-195.3%
-157.4%Profit MarginN/A

Active Signals

COV Signals

●MACD just crossed bullish — momentum is shifting to the upside
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●On a tear — up 18.1% over the last 5 days
●Trading above the 200-day average — the long-term trend is on your side
●Strong cash runway (15 quarters)
●4C filed 2026-01-28
●Strong revenue growth (+373%)
●Small-cap ($20-100M)

EBR Signals

●RSI drifting toward oversold territory — worth watching
●Stochastic just turned bullish from a low level — early reversal sign
●Trading below both moving averages — the trend is working against this one
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (4 quarters) - dilution risk
●4C filed 2026-03-18
●Very high P/S ratio (199.2x)

Ask Scout AI to compare COV and EBR in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
COV Full Analysis → EBR Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).